Our Beneficiary

The IPCR and the Act Smart Initiative

Spread the word

About the Institute for Prostate Cancer Research (IPCR)


Members of the IPCR community include approximately 40 researchers, physicians and other staff at UW Medicine and Fred Hutchinson Cancer Research Center, all dedicated to defeating prostate cancer.

In participating in the Survivors Celebration Breakfast, you and your friends and family will be supporting an institution vital to understanding prostate cancer: the Institute for Prostate Cancer Research (IPCR).

The institute is a collaboration between UW Medicine and Fred Hutchinson Cancer Research Center. A natural outgrowth of established research and clinical collaborations, the IPCR brings together approximately 40 scientists and scientist-clinicians in multiple disciplines. The mission of the IPCR’s world-renowned team is to understand the causes of prostate cancer and its progression, develop new prevention strategies, devise innovative diagnostics and improve survival and quality of life.

Together, these researchers already have identified 80 percent of the genes altered in prostate cancer, developed one of the largest serum and tissue banks in the world, undertaken some of the most advanced studies of bone biology and skeletal metastases, assembled information and genotypes for more than 300 families with hereditary prostate cancer, and developed many new therapeutic strategies. The IPCR is now exploiting this knowledge to change clinical practice to more effectively prevent, detect, and treat prostate cancer.

About the Act Smart Initiative

The Act Smart Initiative is a campaign undertaken by the IPCR that will help move personalized medicine for prostate cancer forward. By utilizing the power of genomic sequencing, creating a flexible new model for testing drugs and therapies, and reaching out to communities — among other important work — the IPCR will help change the delivery of prostate cancer care. Your support will help us build a lasting legacy in the fight against this devastating cancer.

Learn more about the Act Smart Initiative. And thank you for your interest in our work.